CARGO Therapeutics stock hits 52-week low at $3.12
CARGO Therapeutics stock has reached a new 52-week low, trading at $3.09 with a market capitalization of $607 million, as ...
Hospitality & Catering News3h
Country Range Group Kickstarts 2025 with Another Successful Business Development Day Event
Over 36 suppliers showcasing more than 200 products travelled to Doncaster Racecourse on the 28th and 29th of January as the Country Range Group kickstarted the first of its in-demand Business ...
Peninsula biotech moves from IPO to chopping half its workforce in little more than a year
After a nearly $300 million IPO little more than a year ago, a young Peninsula biotech company will discontinue what had been ...
Truist cuts Cargo Therapeutics rating, slashes PT to $7
Truist Securities revised its position on Cargo Therapeutics (NASDAQ:CRGX), currently trading at $13.19 with a market ...
Cargo Therapeutics stock tumbles after trial setback
Investing.com -- Shares of CARGO Therapeutics , Inc. (NASDAQ: CRGX) plummeted 75% following the company's decision to discontinue its Phase 2 clinical trial for firicabtagene autoleucel, citing ...
Cargo Therapeutics downgraded to Hold from Buy at Jefferies
Jefferies downgraded Cargo Therapeutics (CRGX) to Hold from Buy with a price target of $3, down from $32. The company announced the “surprising ...
Central Cee Says Drake Feature Would Have Been ‘Predictable’
Central Cee also recently announced a massive 39-day Can’t Rush Greatness World Tour that begins April 1 in Norway and will ...
CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic Options
CARGO elects to discontinue FIRCE-1, a Phase 2 clinical study of firicabtagene autoleucel (firi-cel)1; Company believes results do not support a ...